Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of overlapping risks of type 2 diabetes and obesity on coronavirus disease severity in the United States
Wataru Ando, Takeshi Horii, Takayuki Uematsu, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Association of Obesity With COVID-19 Severity and Mortality: An Updated Systemic Review, Meta-Analysis, and Meta-Regression
Romil Singh, Sawai Singh Rathore, Hira Khan, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 138
COVID-19 Mortality by Race and Ethnicity in US Metropolitan and Nonmetropolitan Areas, March 2020 to February 2022
Dielle J. Lundberg, Elizabeth Wrigley‐Field, Ahyoung Cho, et al.
JAMA Network Open (2023) Vol. 6, Iss. 5, pp. e2311098-e2311098
Open Access | Times Cited: 60
Diabetes, Metformin and the Clinical Course of Covid-19: Outcomes, Mechanisms and Suggestions on the Therapeutic Use of Metformin
Clifford J. Bailey, Mike Gwilt
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 38
The industrially important genus Kaempferia: An ethnopharmacological review
Arpit Singh, Nitesh Singh, Sanchita Singh, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 20
Soluble Urokinase Plasminogen Activator Receptor (suPAR) Independently Predicts Severity and Length of Hospitalisation in Patients With COVID-19
Helena Enocsson, Cornelia Idoff, Annette Gustafsson, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 34
Geographic and Temporal Patterns in Covid-19 Mortality by Race and Ethnicity in the United States from March 2020 to February 2022
Dielle J. Lundberg, Ahyoung Cho, Rafeya Raquib, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 21
Glycemia control and choice of antihyperglycemic therapy in patients with type 2 diabetes mellitus and COVID-19: a consensus decision of the board of experts of the Russian association of endocrinologists
И. И. Дедов, Н. Г. Мокрышева, М. В. Шестакова, et al.
Diabetes Mellitus (2022) Vol. 25, Iss. 1, pp. 27-49
Open Access | Times Cited: 19
Risk factors for COVID-19 case fatality rate in people with type 1 and type 2 diabetes mellitus: A nationwide retrospective cohort study of 235,248 patients in the Russian Federation
Marina V. Shestakova, O. K. Vikulova, A. R. Elfimova, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 19
Data linkage multiplies research insights across diverse healthcare sectors
T.S. Karin Eisinger‐Mathason, Jonah Leshin, Varun Lahoti, et al.
Communications Medicine (2025) Vol. 5, Iss. 1
Open Access
Metformin in SARS-CoV-2 infection: A hidden path – from altered inflammation to reduced mortality. A review from the literature
Ana Realista Pedrosa, Diana Martins, Manfredi Rizzo, et al.
Journal of Diabetes and its Complications (2023) Vol. 37, Iss. 2, pp. 108391-108391
Open Access | Times Cited: 10
Clinical Interest of Serum Alpha-2 Macroglobulin, Apolipoprotein A1, and Haptoglobin in Patients with Non-Alcoholic Fatty Liver Disease, with and without Type 2 Diabetes, before or during COVID-19
Olivier Deckmyn, Thierry Poynard, Pierre Bédossa, et al.
Biomedicines (2022) Vol. 10, Iss. 3, pp. 699-699
Open Access | Times Cited: 15
U-shaped association between abnormal serum uric acid levels and COVID-19 severity: reports from the Japan COVID-19 Task Force
Takahiro Fukushima, Shotaro Chubachi, Ho Namkoong, et al.
International Journal of Infectious Diseases (2022) Vol. 122, pp. 747-754
Open Access | Times Cited: 15
Obesity and metabolic dysfunction drive sex-associated differential disease profiles in hACE2-mice challenged with SARS-CoV-2
Katherine S. Lee, Brynnan P. Russ, Ting Y. Wong, et al.
iScience (2022) Vol. 25, Iss. 10, pp. 105038-105038
Open Access | Times Cited: 15
Semi-automated Segmentation and Quantification of Perivascular Spaces at 7 Tesla in COVID-19
Mackenzie Langan, D. Smith, Gaurav Verma, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 14
Analysis of risk factors for COVID-19-related fatal outcome in 337991 patients with type 1 and type 2 diabetes mellitus in 2020–2022 years: Russian nationwide retrospective study
Н. Г. Мокрышева, М. В. Шестакова, Olga Konstantinovna Vikulova, et al.
Diabetes Mellitus (2022) Vol. 25, Iss. 5, pp. 404-417
Open Access | Times Cited: 13
Biofunctional properties and plant physiology of Kaempferia spp.: Status and trends
Akiko Hashiguchi, May San Thawtar, Teerarat Duangsodsri, et al.
Journal of Functional Foods (2022) Vol. 92, pp. 105029-105029
Open Access | Times Cited: 11
Impact of Type 2 Diabetes Mellitus on the Incidence and Outcomes of COVID-19 Needing Hospital Admission According to Sex: Retrospective Cohort Study Using Hospital Discharge Data in Spain, Year 2020
José M. de Miguel‐Yanes, Rodrigo Jiménez‐García, Javier de Miguel‐Díez, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 9, pp. 2654-2654
Open Access | Times Cited: 9
Impact of diabetes on COVID-19 patient health outcomes in a vulnerable racial minority community
Stefan Hamaway, Uchechukwu Nwokoma, Michael S. Goldberg, et al.
PLoS ONE (2023) Vol. 18, Iss. 7, pp. e0286252-e0286252
Open Access | Times Cited: 5
Risk analysis of COVID-19 hospitalization and critical care by race and region in the United States: a cohort study
Mitsuki Jimbo, Sakae Saito, Takayuki Uematsu, et al.
BMC Public Health (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 3
HbA1c measurement may save COVID‐19 inpatients from overlooked diabetes
Ayaka Yoroidaka, Seiichiro Kurita, Toshiyuki Kita
Journal of Diabetes Investigation (2022) Vol. 13, Iss. 11, pp. 1925-1933
Open Access | Times Cited: 4
Case report of a Japanese patient with chronic renal failure who developed SARS‐CoV‐2 in a hospital cluster during treatment for acute respiratory failure: An autopsy report
Yoshifumi Amari, Satoshi Morimoto, T. Teranishi, et al.
Clinical Case Reports (2022) Vol. 10, Iss. 7
Open Access | Times Cited: 3
Potential Effects of Hyperglycemia on SARS-CoV-2 Entry Mechanisms in Pancreatic Beta Cells
Tara M. Michaels, M. Faadiel Essop, Danzil Joseph
Viruses (2024) Vol. 16, Iss. 8, pp. 1243-1243
Open Access
Symptoms, Course, and Factors Related to Long-Term Morbidity, Including Differences between Infection Strains, in Patients with Long COVID in a Primary Care Clinic in Japan: An Observational Study
Kenji Baba, S Kawai, Satoshi Iwase, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 17, pp. 5019-5019
Open Access
Bayesian networks and imaging-derived phenotypes highlight the role of fat deposition in COVID-19 hospitalisation risk
Tom Waddell, Ana I. L. Namburete, P. Duckworth, et al.
Frontiers in Bioinformatics (2023) Vol. 3
Open Access | Times Cited: 1
Immune checkpoint inhibitor therapy and elevated levels of C-reactive protein associated with COVID-19 aggravation in patients with lung cancer
Masatoshi Maki, Ryo Takada, Akihiko Taniguchi, et al.
Journal of Pharmaceutical Health Care and Sciences (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top